McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric
Verdun, Quebec, Canada
Psychiatric hospital in Montreal, Quebec
6875 Bd LaSalle, Verdun, QC H4H 1R3
About McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric
The Douglas Mental Health University Institute is a Canadian psychiatric hospital located in the borough of Verdun in the city of Montreal, Quebec. It is also a teaching hospital affiliated with McGill University. The nearest Montreal Metro station is Monk.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Genentech, Inc.
2
Hoffmann-La Roche
2
Clinical Trials at McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric
During the past decade, McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)
2011-04-30
2014-02-28
Completed
448
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
2012-10-24
2015-06-12
Completed
542
A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab
2012-12-07
2017-02-08
Completed
360
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
2014-03-27
2021-04-16
Completed
389
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric
According to Clinical.Site data, the most researched conditions in "McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric" are
"Alzheimer's Disease" (4 trials). Many other conditions were trialed in "McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric" in a lesser frequency.
Clinical Trials Intervention Types at McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric
Most popular intervention types in "McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Crenezumab" (1 trials), "Donepezil" (1 trials), "Galantamine" (1 trials) and "Gantenerumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric
The vast majority of trials in "McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric" are
4 trials for "All" genders.
Clinical Trials Status at McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric
Currently, there are NaN active trials in "McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".